Dr. Ken H. YoungThe University of Texas MD Anderson Cancer Center, USA.
Biography
Degree-Granting Education
Zhejiang University School of Medicine, Zhejiang, China, MD, 1984, Medicine
University of Lund School of Medicine, Malmo, Sweden, PhD, 1995, Department of Pathology and Laboratory Medicine
Postgraduate Training
Research Fellowship, Cardiovascular Hematology Program, University of Oklahoma Health Science Center, Oklahoma City, OK, 6/1995-6/1999
Clinical Residency, Oregon Health and Science University, Portland, OR, 7/1999-6/2003
Clinical Fellowship, University of Nebraska Medical Center, Omaha, NE, 7/2003-6/2004
Research Interest
1. Acute myelogenous leukemia - WHO classification and clinical issues
2. Peripheral T-cell lymphoma - Current WHO classification and new challenge
3. New WHO Classification of Lymphoid Neoplasms
4. Dendritic and Histiocytic Neoplasms - New WHO Classification and clinical issues
5. Myelodysplastic Syndrome - WHO Classification and new challenge
6. Automated Hematology Analysis
7. Molecular Diagnostics and Cytogenetics in Lymphoma and Leukemia Applications
8. Hodgkin lymphoma - Diagnosis, Differential Diagnosis and Molecular Mechanism
9. Bone Marrow and Peripheral Blood Pathology (AACLS lecture award)
10. Flow cytometry and its application in hematologic malignancies
11. Lymphoid Neoplasms ? Where we stand now for the standard care in the molecular century
12. Molecular mechanisms of DLBCL ? what relevant to the clinical management
13. EBV+ Lymphoma: Biology, Mechanism and Clinical Management